These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Etryptamine acetate in general practice. CHOGICH JC J Neuropsychiatr; 1961; 3():96-7. PubMed ID: 13879126 [No Abstract] [Full Text] [Related]
5. Treatment of geriatric patients with etryptamine acetate. KIESSLING AJ J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873 [No Abstract] [Full Text] [Related]
6. The effect of D, L-alpha-ethyltryptamine acetate on serotonin metabolism. GREIG ME; GIBBONS AJ Arch Int Pharmacodyn Ther; 1962 Mar; 136():147-52. PubMed ID: 13901665 [No Abstract] [Full Text] [Related]
7. [PROSPECTIVES FOR THE USE OF MONOAMINE OXIDASE INHIBITORS IN PEDIATRICS]. ANSANELLI V Pediatria (Napoli); 1964; 72():133-9. PubMed ID: 14163248 [No Abstract] [Full Text] [Related]
9. [Contribution to the study of attenzione in subjects subjected to thymoleptic therapy (imipramine, iproniazid, phenelzine, etryptamine)]. MEDAGLINI E Riv Sper Freniatr Med Leg Alien Ment; 1962 Jun; 86():494-500. PubMed ID: 14471966 [No Abstract] [Full Text] [Related]
11. Anomalous actions of monoamine oxidase inhibitors. PSCHEIDT GR Ann N Y Acad Sci; 1963 Jul; 107():1057-67. PubMed ID: 13972407 [No Abstract] [Full Text] [Related]
12. Memory changes with MAO inhibitor therapy. HANKOFF LD; HELLER B Am J Psychiatry; 1960 Aug; 117():151-2. PubMed ID: 14399507 [No Abstract] [Full Text] [Related]
13. Further studies on the neuropharmacological effects of etryptamine acetate. MATTHEWS RJ Arch Int Pharmacodyn Ther; 1963 Mar; 142():90-110. PubMed ID: 13933880 [No Abstract] [Full Text] [Related]
14. THE SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF SOME CHLORO-ALPHA-ALKYLTRYPTAMINES. WHITTLE BA; YOUNG EH J Med Chem; 1963 Jul; 6():378-80. PubMed ID: 14184890 [No Abstract] [Full Text] [Related]
15. ROLE OF THE POLYMETHYLENE CHAIN IN DERIVATIVES OF DEMECARIUM BROMIDE ON THE INHIBITION OF MONOAMINE OXIDASE. PANT MC; PARMAR SS; BHARGAVA KP J Pharm Pharmacol; 1964 Jul; 16():503-4. PubMed ID: 14207098 [No Abstract] [Full Text] [Related]
16. REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR. HODGE JV; OATES JA; SJOERDSMA A Clin Pharmacol Ther; 1964; 5():149-55. PubMed ID: 14155155 [No Abstract] [Full Text] [Related]
17. [NEW DEVELOPMENTS IN ANTIDEPRESSIVE DRUG THERAPY]. DEGIACOMO U Clin Eur; 1963; 30():121-5. PubMed ID: 14079215 [No Abstract] [Full Text] [Related]
18. CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE. LESSIN AW; LONG RF; PARKES MW Br J Pharmacol Chemother; 1965 Feb; 24(1):49-67. PubMed ID: 14301999 [No Abstract] [Full Text] [Related]
19. [Poisoning in treatment with monoamine oxidase inhibitors and imipramine]. JENSEN E Ugeskr Laeger; 1962 May; 124():616. PubMed ID: 14451634 [No Abstract] [Full Text] [Related]
20. A STUDY OF THE POTENTIATION OF TRYPTAMINE BY MONOAMINE OXIDASE INHIBITORS IN THE DOG. EBLE JN J Pharmacol Exp Ther; 1965 Apr; 148():48-53. PubMed ID: 14279183 [No Abstract] [Full Text] [Related] [Next] [New Search]